Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Lilly Hit with Bribery Charges in China

publication date: Aug 23, 2013
Eli Lilly has joined the list of big pharmas that have been accused of bribing doctors to promote sales in China. A former manager of the company, known by the pseudonym of Wei Wang, told a private China newspaper that the company paid 30 million RMB ($4.9 million) in inducements raise sales of its insulin products over a one-year period during 2011-12. Lilly is now the fourth MNC to have a former employee make this type of accusation. The others are GlaxoSmithKline, Novartis and Sanofi. More details....

Stock Symbols: (NYSE: LLY) (NYSE GSK) (NYSE: NVS) (NYSE: SNY)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital